Literature DB >> 27329684

Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence.

Kyoji Okita1,2, Nicole Petersen1, Chelsea L Robertson2,3, Andy C Dean1,4, Mark A Mandelkern2,5, Edythe D London1,2,3,4.   

Abstract

Women differ from men in smoking-related behaviors, among them a greater difficulty in quitting smoking. Unlike female smokers, male smokers have lower striatal dopamine D2-type receptor availability (binding potential, BPND) than nonsmokers and exhibit greater smoking-induced striatal dopamine release. Because dopamine D2-type autoreceptors in the midbrain influence striatal dopamine release, a function that has been linked to addiction, we tested for sex differences in midbrain dopamine D2-type receptor BPND and in relationships between midbrain BPND, nicotine dependence and striatal dopamine D2-type receptor BPND. Positron emission tomography was used with [18F]fallypride to measure BPND in a midbrain region, encompassing the substantia nigra and ventral tegmental area, in 18 daily smokers (7 women, 11 men) and 19 nonsmokers (10 women, 9 men). A significant sex-by-group interaction reflected greater midbrain BPND in female but not male smokers than in corresponding nonsmokers (F1, 32=5.089, p=0.03). Midbrain BPND was positively correlated with BPND in the caudate nucleus and putamen in nonsmokers and female smokers but not in male smokers and with nicotine dependence in female but not in male smokers. Striatal BPND was correlated negatively with nicotine dependence and smoking exposure. These findings extend observations on dopamine D2-type receptors in smokers and suggest a sex difference in how midbrain dopamine D2-type autoreceptors influence nicotine dependence.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27329684      PMCID: PMC5061883          DOI: 10.1038/npp.2016.105

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  56 in total

1.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

2.  Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons.

Authors:  Michael J Beckstead; David K Grandy; Kevin Wickman; John T Williams
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

Review 3.  Sex differences in nicotine reinforcement and reward: influences on the persistence of tobacco smoking.

Authors:  Kenneth A Perkins
Journal:  Nebr Symp Motiv       Date:  2009

4.  Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons.

Authors:  E V Gurevich; J N Joyce
Journal:  Neuropsychopharmacology       Date:  1999-01       Impact factor: 7.853

Review 5.  The role of mesoaccumbens dopamine in nicotine dependence.

Authors:  David J K Balfour
Journal:  Curr Top Behav Neurosci       Date:  2015

6.  Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers.

Authors:  Amira K Brown; Mark A Mandelkern; Judah Farahi; Chelsea Robertson; Dara G Ghahremani; Brittany Sumerel; Nathasha Moallem; Edythe D London
Journal:  Int J Neuropsychopharmacol       Date:  2012-01-16       Impact factor: 5.176

7.  Female sex and oral contraceptive use accelerate nicotine metabolism.

Authors:  Neal L Benowitz; Christina N Lessov-Schlaggar; Gary E Swan; Peyton Jacob
Journal:  Clin Pharmacol Ther       Date:  2006-05       Impact factor: 6.875

Review 8.  The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.

Authors:  P Sokoloff; J Diaz; B Le Foll; O Guillin; L Leriche; E Bezard; C Gross
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-02       Impact factor: 4.388

9.  D3 dopamine autoreceptors do not activate G-protein-gated inwardly rectifying potassium channel currents in substantia nigra dopamine neurons.

Authors:  Viviana Davila; Zhen Yan; Liviu C Craciun; Diomedes Logothetis; David Sulzer
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

10.  Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.

Authors:  Vanessa L Cropley; Robert B Innis; Pradeep J Nathan; Amira K Brown; Janet L Sangare; Alicja Lerner; Yong Hoon Ryu; Kelly E Sprague; Victor W Pike; Masahiro Fujita
Journal:  Synapse       Date:  2008-06       Impact factor: 2.562

View more
  11 in total

Review 1.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

2.  Striatal Dopamine D2/D3 Receptor Availability Varies Across Smoking Status.

Authors:  Corinde E Wiers; Elizabeth A Cabrera; Dardo Tomasi; Christopher T Wong; Şükrü B Demiral; Sung Won Kim; Gene-Jack Wang; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2017-06-23       Impact factor: 7.853

Review 3.  Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective.

Authors:  Sabrina Rahman Archie; Sejal Sharma; Elizabeth Burks; Thomas Abbruscato
Journal:  Neurotoxicology       Date:  2022-02-09       Impact factor: 4.294

4.  Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT.

Authors:  Szeman Ruby Chan; Kelley Salem; Justin Jeffery; Ginny L Powers; Yongjun Yan; Kooresh I Shoghi; Aparna M Mahajan; Amy M Fowler
Journal:  J Nucl Med       Date:  2017-12-07       Impact factor: 10.057

Review 5.  Tactics for preclinical validation of receptor-binding radiotracers.

Authors:  Susan Z Lever; Kuo-Hsien Fan; John R Lever
Journal:  Nucl Med Biol       Date:  2016-09-03       Impact factor: 2.408

6.  Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokers.

Authors:  Yasmin Zakiniaeiz; Ansel T Hillmer; David Matuskey; Nabeel Nabulsi; Jim Ropchan; Carolyn M Mazure; Marina R Picciotto; Yiyun Huang; Sherry A McKee; Evan D Morris; Kelly P Cosgrove
Journal:  Neuropsychopharmacology       Date:  2019-07-03       Impact factor: 7.853

7.  Striatal dopamine D2-type receptor availability and peripheral 17β-estradiol.

Authors:  Nicole Petersen; Andrea J Rapkin; Kyoji Okita; Kaitlin R Kinney; Tomi Mizuno; Mark A Mandelkern; Edythe D London
Journal:  Mol Psychiatry       Date:  2021-01-08       Impact factor: 13.437

8.  Enhanced Amygdala-Striatal Functional Connectivity during the Processing of Cocaine Cues in Male Cocaine Users with a History of Childhood Trauma.

Authors:  Anne Marije Kaag; Liesbeth Reneman; Judith Homberg; Wim van den Brink; Guido A van Wingen
Journal:  Front Psychiatry       Date:  2018-03-12       Impact factor: 4.157

Review 9.  Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies.

Authors:  Abhishekh H Ashok; Yuya Mizuno; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2019-03-18       Impact factor: 4.530

10.  Sex-dependent alterations of dopamine receptor and glucose transporter density in rat hypothalamus under long-term clozapine and haloperidol medication.

Authors:  Marie-Luise Bouvier; Karin Fehsel; Andrea Schmitt; Eva Meisenzahl-Lechner; Wolfgang Gaebel; Martina von Wilmsdorff
Journal:  Brain Behav       Date:  2020-06-11       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.